In the News
Based on a discovery by UVA researchers last year, new findings suggest the drug fluvoxamine may stop COVID symptoms from worsening.
Scientists at UVA urge more study before considering human testing of the small-molecule drug originally developed to fight cancer.
Research into hypersonic travel is soaring again in the United States, and UVA Engineering is contributing historic expertise.
A UVA-led study examined specialists who use explosives to enter buildings, and found statistically significant differences in blood flow, brain structure and brain activity.
CNN’s chief medical correspondent interviewed UVA’s Dr. Amy Mathers about wastewater surveillance testing on his far-reaching podcast, “Coronavirus: Fact vs. Fiction.”
Dr. Catherine Varney breaks down how obesity increases complications from COVID-19 infection and increases one’s risk of getting infected in the first place.
A new method developed at the School of Medicine could boost efforts to prevent viral infections such as COVID-19.
Bees, essential pollinators of plants and crops, are on the decline. Environmental scientists are seeking reasons.